Skip to main content
Clinical Trials/NCT01585883
NCT01585883CompletedNot Applicable

A Pilot Trial of a Self-Management Intervention for Breathlessness in Lung Cancer

University Health Network, Toronto1 site in 1 country56 target enrollmentStarted: November 30, 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
56
Locations
1
Primary Endpoint
Perceived severity of breathlessness

Study Overview

Brief Summary

The purpose of this study is to investigate the suitability and practicality of a coaching and support intervention in helping patients to use daily strategies for managing breathlessness. Also, the investigators will try to understand how useful it is in helping patients to reduce intensity of breathlessness and its impact their quality of life.

Detailed Description

Lung cancer is common worldwide and is a leading cause of death. Breathlessness (dyspnea or shortness of breath) is a highly prevalent clinical problem in lung cancer, developing early in 25-50% of patients due to advanced stage at presentation. It persists in 60% of survivors' post-lung resection and worsens with progressive disease with rates as high as 90% reported in the final months of life. Breathlessness is associated with a high degree of unpleasantness, negatively impacts on daily functioning, and multiple domains of quality of life, triggers fear and anxiety in patients and their family, and contributes to symptom specific and psychological distress. It is also costly to the health system as it contributes to urgent care use and hospitalization. The purpose of this pilot trial is to evaluate feasibility and acceptability of a self-management intervention for breathlessness in lung cancer.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Arms & Interventions

Self-management Intervention

Experimental

Individual, face-to-face 7-session self-management intervention delivered by a specialist oncology nurse/clinical case manager as a home-based approach using a manual for each session.

Intervention: Self-management Intervention (Behavioral)

Standard of care

Active Comparator

Patients in this condition will receive usual care as decided by their oncology clinic team or physician.

Intervention: Self-management Intervention (Behavioral)

Outcomes

Primary Outcomes

Perceived severity of breathlessness

Time Frame: 8 weeks

Measured by Numeric Rating Scale for breathlessness intensity.

Affective distress of breathlessness

Time Frame: 8 weeks

Measured by Distress of Breathlessness Numerical Rating Scale.

Dyspnea with activities of daily living and exercise

Time Frame: 8 weeks

Measured by (a) Chronic Respiratory Questionnaire, (b) Medical Research Council Dyspnea Scale, and (c) BORG scale prior to, during, and at the end of the 6-Minute-Walk Test.

Secondary Outcomes

  • Self-efficacy and mastery for managing breathlessness(8 weeks)
  • Beliefs about breathlessness(8 weeks)
  • Adherence and Use of Self-Management Strategies(8 weeks)
  • Exercise capacity(8 weeks)
  • Psychological distress(8 weeks)
  • Quality of life(8 weeks)
  • Health care utilization(8 weeks)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Self-Management Intervention for... | Clinical Trial